| Inhibition of In-Stent Stenosis by Oral Administration of Bindarit in Porcine Coronary Arteries. | |
| | |
MedLine Citation:
|
PMID: 21852559 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVE: We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth muscle cell proliferation and migration and neointimal macrophage content, effects associated with the inhibition of MCP-1/CCL2 production. The aim of the current study was to evaluate the efficacy of bindarit on in-stent stenosis in the preclinical porcine coronary stent model. METHODS AND RESULTS: One or 2 bare metal stents (Multi-Link Vision, 3.5 mm) were deployed (1:1.2 oversize ratio) in the coronary arteries of 42 pigs (20 bindarit versus 22 controls). Bindarit (50 mg/kg per day) was administered orally from 2 days before stenting until the time of euthanasia at 7 and 28 days. Bindarit caused a significant reduction in neointimal area (39.4%, P<0.001, n=9 group), neointimal thickness (51%, P<0.001), stenosis area (37%, P<0.001), and inflammatory score (40%, P<0.001) compared with control animals, whereas there was no significant difference in the injury score between the 2 groups. Moreover, treatment with bindarit significantly reduced the number of proliferating cells (by 45%, P<0.05; n=6 group) and monocyte/macrophage content (by 55%, P<0.01; n=5-6 group) in stented arteries at day 7 and 28, respectively. These effects were associated with a significant (P<0.05) reduction of MCP-1 plasma levels at day 28. In vitro data showed that bindarit (10-300 μmol/L) reduced tumor necrosis factor-α (50 ng/mL)-induced pig coronary artery smooth muscle cell proliferation and inhibited MCP-1 production. CONCLUSIONS: Our results show the efficacy of bindarit in the prevention of porcine in-stent stenosis and support further investigation for clinical application of this compound. |
| | |
Authors:
|
Armando Ialenti; Gianluca Grassia; Peter Gordon; Marcella Maddaluno; Maria Vittoria Di Lauro; Andrew H Baker; Angelo Guglielmotti; Antonio Colombo; Giuseppe Biondi; Simon Kennedy; Pasquale Maffia |
Related Documents
:
|
7135189 - Arteriovenous shunts between dural branches of the carotid artery and the cavernous sinus. 3874439 - Closure of carotid-cavernous fistulae by use of a fibrin adhesive system. 480509 - Urogenital sinus abnormalities in the female patient. 9202779 - The clinoidal space: anatomical review and surgical implications. 6792879 - Traumatic aneurysms of cavernous internal carotid artery with secondary epistaxis. 20943409 - Coronary artery anatomy in anatomically corrected malposition of the great arteries and... 15886949 - Local administration of nf-kappa b decoy oligonucleotides to prevent restenosis after b... 2146039 - Iliofemoral arterial complications of balloon angioplasty for systemic obstructions in ... 985079 - Simultaneous bilateral carotid endarterectomies. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-8-18 |
Journal Detail:
|
Title: Arteriosclerosis, thrombosis, and vascular biology Volume: - ISSN: 1524-4636 ISO Abbreviation: - Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-8-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9505803 Medline TA: Arterioscler Thromb Vasc Biol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Directed Differentiation of Skin-Derived Precursors Into Functional Vascular Smooth Muscle Cells.
Next Document: Focal adhesion kinase-related nonkinase inhibits vascular smooth muscle cell invasion by focal adhes...